𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of ABVD chemotherapy and a regimen including radiotherapy in patients with limited-stage Non-Hodgkin’s lymphoma

✍ Scribed by Carol S. Portlock

Book ID
107546471
Publisher
Current Science Inc.
Year
2006
Tongue
English
Weight
65 KB
Volume
8
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized study of radiotherapy versu
A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-hodgkin's lymphomas
✍ Nis I. Nissen; Jens Ersbøll; Hanne Sand Hansen; Sven Walbom-Jørgensen; Jens Pede 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

In a randomized, prospective trial from 1974-1978, 73 patients with non-Hodgkin's lymphomas in clinical Stage I or II were treated with extended field radiotherapy alone (RT) or RT plus adjuvant chemotherapy with vincristine, streptonigrin, cyclophosphamide and prednisone (RT + CT). With a median fo

Severe lung toxicity with a weekly low d
Severe lung toxicity with a weekly low dose chemotherapy regimen in patients with non-Hodgkin's lymphoma
✍ M. Quigley; M. Brada; C. Heron; Professor A. Horwich 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 789 KB

Nineteen patients in poor prognostic subgroups of aggressive non-Hodgkin's lymphoma (NHL) were treated with weekly chemotherapy consisting of low dose mitoxantrone and cyclophosphamide alternating with bleomycin and vincristine together with continuous oral prednisolone. Six patients developed pneum

A randomized trial of two types of adjuv
A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphoma
✍ J. Wagstaff; I. Todd; D. Deakin; P. Wilkinson; J. H. Scarffe; M. Harris; M. Jone 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 600 KB

This paper reports the 8-year results of comparing the use of two types of adjuvant chemotherapy following involved field radiotherapy for clinical stages I and II high-grade non-Hodgkin's lymphoma. Twenty-four patients received 6 weeks of VAP plus 2 years of oral maintenance chemotherapy, and 30 ha